Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SAMI HAYEK

Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology

NPI
1992024483
CMS profile
733505
Location
COVINA, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$9,576.38

90 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Honoraria $6,000.00 1
Food and Beverage $1,919.93 86
Travel and Lodging $1,656.45 3

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 2; records 51–90 of 90 matching records. This page contains 40 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SAMI HAYEK

NPI 1992024483 · CMS profile ID 733505

Allopathic & Osteopathic Physicians / Internal Medicine / Interventional Cardiology

COVINA, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–90 of 90 matching records. This page contains 40 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1992024483?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SAMI HAYEK, NPI 1992024483, CMS profile ID 733505. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–90 of 90 matching records. This page contains 40 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1992024483?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). SAMI HAYEK, NPI 1992024483, CMS profile ID 733505. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–90 of 90 matching records. This page contains 40 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1992024483?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
SAMI HAYEK, NPI 1992024483, CMS profile ID 733505, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–90 of 90 matching records. This page contains 40 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1992024483?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

90 matching records · $9,576.38 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 90 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–90 of 90.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Medtronic, Inc. $18.5307/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026461771 CMS
ABIOMED $30.5306/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044719871 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $15.2906/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 984142537 CMS
Lexicon Pharmaceuticals, Inc. $22.2506/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040765301 CMS
PFIZER INC. $9.6706/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049942363 CMS
PFIZER INC. $15.0406/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049953835 CMS
Novartis Pharmaceuticals Corporation $11.7506/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992327753 CMS
E.R. Squibb & Sons, L.L.C. $13.3006/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015642055 CMS
Abbott Laboratories $9.2206/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1018082095 CMS
Abbott Laboratories $14.9305/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1018155975 CMS
Abbott Laboratories $9.7305/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1018081677 CMS
Abbott Laboratories $16.7205/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019386599 CMS
ABIOMED $29.4605/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044719601 CMS
PFIZER INC. $21.2805/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049355161 CMS
Medtronic, Inc. $24.2505/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026461769 CMS
ABIOMED $27.2605/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044719715 CMS
CARDIVA MEDICAL, INC. $124.4505/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1039477029 CMS
Medtronic, Inc. $27.2505/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026461767 CMS
ABIOMED $6.5805/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044719883 CMS
Abbott Laboratories $16.5104/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019386433 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.4404/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996529632 CMS
Novo Nordisk Inc $22.5104/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002998279 CMS
Boston Scientific Corporation $16.7203/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022099705 CMS
Novartis Pharmaceuticals Corporation $9.7103/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992327741 CMS
Abbott Laboratories $3.1003/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1018216531 CMS
Abbott Laboratories $2.4703/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1018216865 CMS
Abbott Laboratories $13.0603/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019386789 CMS
Novartis Pharmaceuticals Corporation $13.2003/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992327745 CMS
ABIOMED $5.7503/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044719535 CMS
Novartis Pharmaceuticals Corporation $18.4403/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992327737 CMS
PFIZER INC. $21.2802/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049562773 CMS
Edwards Lifesciences Corporation $135.3202/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023165537 CMS
Amgen Inc. $27.4402/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020107861 CMS
AstraZeneca Pharmaceuticals LP $18.6902/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014806421 CMS
Kiniksa Pharmaceuticals, Ltd. $23.1402/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142990018 CMS
Novartis Pharmaceuticals Corporation $16.5602/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992327733 CMS
CARDIVA MEDICAL, INC. $99.1701/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1039477025 CMS
PFIZER INC. $20.6901/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049105223 CMS
ABIOMED $27.6501/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044719769 CMS
Abbott Laboratories $6.2801/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019323945 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,073.43 32
PY2020 $1,038.14 47
PY2021 $2,598.38 100
PY2022 $1,766.03 79
PY2023 $9,576.38 90
PY2024 $2,404.28 90
PY2025 $1,849.55 87

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $33,567.08 19
PY2024 Recipient $104.27 1
PY2023 Recipient $114.67 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

19 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Boehringer Ingelheim International GmbH $186.94 10/01/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220785119
Principal investigator 1 Boehringer Ingelheim International GmbH $186.94 09/01/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220785113
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $19,000.00 08/15/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220817928
Principal investigator 1 Boehringer Ingelheim International GmbH $186.94 08/01/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220785117
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $11,900.00 07/09/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220817926
Principal investigator 1 Boehringer Ingelheim International GmbH $186.94 07/01/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220785115
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $115.08 07/01/2025 Non-covered Recipient Entity
Mckesson
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220796259
Principal investigator 1 Boehringer Ingelheim International GmbH $39.96 06/24/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220785105
Principal investigator 1 Boehringer Ingelheim International GmbH $146.00 06/24/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220785107
Principal investigator 1 Boehringer Ingelheim International GmbH $122.14 06/24/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220785109
Principal investigator 1 Boehringer Ingelheim International GmbH $186.94 06/01/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220785111
Principal investigator 1 Boehringer Ingelheim International GmbH $186.94 05/01/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220785095
Principal investigator 1 Boehringer Ingelheim International GmbH $11.66 04/23/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220785097
Principal investigator 1 Boehringer Ingelheim International GmbH $199.80 04/23/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220785099
Principal investigator 1 Boehringer Ingelheim International GmbH $365.00 04/23/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220785101
Principal investigator 1 Boehringer Ingelheim International GmbH $122.14 04/23/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220785103
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $22.17 04/15/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220817922
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $140.49 04/02/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220817924
Principal investigator 1 Boehringer Ingelheim International GmbH $261.00 04/01/2025 Non-covered Recipient Entity
Valley Clinical Trials
IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction No dispute reported 06/30/2026 1220785093